DeepFAN improved lung nodule diagnosis in China’s first multi-center trial, raising junior radiologists’ accuracy, confidence and consistency.
DeepFAN AI Model Significantly Boosts Lung Nodule Diagnosis Read More »
A concise playbook for healthcare leaders to prioritize and implement AI across diagnostics, clinical care, public health, and operations.
Strategic AI Adoption in Healthcare: A Practical Guide for Leaders Read More »
BiteLabs joins the Health + AI Tech Show.
New Partner: BiteLabs is joining us on 29 April Read More »
New Partner: Centre of Excellence for Regulatory Science in AI & Digital Health
CERSI-AI joins the Health + AI Tech Show Read More »
Explore how AI excels at pattern-based diagnoses like rashes, why human clinicians remain essential for trust and context, and how both can work together.
AI’s Diagnostic Promise and Patient Trust: When Pattern Recognition Meets Care Read More »
Insilico Medicine convenes an industry-first Longevity Board to marry Big Pharma expertise with AI drug discovery, targeting dual-purpose therapies to extend healthspan.
Explore how AI-powered ‘Uber for nurses’ platforms affect pay, worker rights, patient safety and regulation, with practical guidance for healthcare leaders.
AI-Driven Gig Nursing: Risks for Workforce, Patients and Health Systems Read More »
How AI is reshaping biotech: protein folding, drug discovery, personalized medicine, and next steps for validation, data standards, and regulation.
The AI Revolution in Biotechnology: From Protein Folding to Faster Drug Discovery Read More »
Buckinghamshire Healthcare NHS Trust is rolling out System C ambient voice scribing into CareFlow EPR for outpatient clinics, aligned with NHS England guidance.
Buckinghamshire Trust adopts System C AI scribing for CareFlow EPR Read More »
A concise overview of AI adoption in European healthcare diagnostics, workforce training needs, public trust, and policy steps to integrate AI responsibly.
The State of AI in Healthcare Diagnostics: Workforce, Trust, and Policy Priorities Read More »
